The role of p27Kip1 in maintaining the levels of D-type cyclins in vivo

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1691, Issue 2-3, 2004, Pages 105-116

  Bryja, Vítězslav ^a,b   Pacherník, Jiří ^a,c   Faldíková, Ludmila ^d   Krejčí, Pavel ^e   Pogue, Robert ^e   Nevřivá, Iveta ^c   Dvořák, Petr ^a,b,c   Hampl, Aleš ^a,b,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c MENDEL UNIVERSITY IN BRNO   (Czech Republic)

^d VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

D type cyclin; Differentiation; Leydig cell; Lung; p27; p27 deficient mouse; Thymus

Indexed keywords

CYCLIN D; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; PROTEIN P27;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DATA ANALYSIS; ENZYME INHIBITION; IN VIVO STUDY; LEYDIG CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; TESTIS; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION; LEYDIG CELLS; LUNG; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; TESTOSTERONE; THYMUS GLAND; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 1942508891     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2004.01.001     Document Type: Article

References (33)

1. 1-phase progression. Genes Dev. 13:1999;1501-1512.
2. Gao C.Y., Zelenka P. Cyclins, cyclin-dependent kinases and differentiation. BioEssays. 19:1997;307-315.
3. Bartkova J., Lukas J., Strauss M., Bartek J. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene. 17:1998;1027-1037.
4. Bartkova J., Rajpert-de Meyts E., Skakkebak N.E., Bartek J. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. J. Pathol. 187:1999;573-581.
5. Doglioni C., Chiarelli C., Macri E., Dei Tos A.P., Meggiolaro E., Dalla Palma P., Barbareschi M. Cyclin D3 expression in normal, reactive and neoplastic tissues. J. Pathol. 185:1998;159-166.
6. Savatier P., Lapillonne H., van Grunsven L.A., Rudkin B.B., Samarut J. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene. 12:1995;309-322.
7. Kranenburg O., de Groot R.P., Van der Eb A., Zantema A. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene. 10:1995;87-95.
8. kip1 in the in vitro differentiation of murine keratinocytes. Cell Growth Differ. 8:1997;203-211.
9. Reichert M., Eick D. Analysis of cell cycle arrest in adipocyte differentiation. Oncogene. 18:1999;459-466.
10. Hampl A., Pacherník J., Dvorak P. Levels and interactions of p27, cyclin D3 and CDK4 during the formation and maintenance of the corpus luteum in mice. Biol. Reprod. 62:2000;1393-1401.
11. kip1 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1999;1571-1583.
12. cip1. Mol. Cell. Biol. 20:2000;8748-8757.
13. kip1 is required for mouse mammary gland morphogenesis and function. J. Cell Biol. 153:2001;917-931.
14. Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development. 126:1999;4027-4037.
15. Kip1 in mice. Mol. Cell. Biol. 21:2001;1319-1328.
16. Kip1 gene restores normal development in cyclin D1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 98:2001;194-199.
17. Dyer M.A., Cepko C.L. Control of Müller glial cell proliferation and activation following retinal injury. Nat. Neurosci. 3:2000;873-880.
18. Kip1-deficient mice. Cell. 85:1996;733-744.
19. Schumacher M., Schaefer G., Holzstein A.F., Hilz H. Rapid isolation of mouse Leydig cells by centrifugation in Percoll density gradient with complete retention of morphological and biochemical integrity. FEBS Lett. 91:1978;333-338.
20. Levy H., Deane H.W., Rubin B.L. Visualization of 3beta-ol-dehydrogenase activity in tissues of intact and hypophysectomized rats. Endocrinology. 65:1959;933-943.
21. Zhang Q., Wang X., Wolgemuth D.J. Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis. Endocrinology. 140:1999;2790-2800.
22. Kip2 during mouse development. Anat. Embryol. 203:2001;77-87.
23. Benton L., Shan L.-X., Hardy M.P. Differentiation of adult Leydig cells. J. Steroid Biochem. Mol. Biol. 53:1995;61-68.
24. Cenciarelli C., De Santa F., Puri P.L., Mattei E., Ricci L., Bucci F., Felsani A., Caruso M. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol. Cell. Biol. 19:1999;5203-5217.
25. Huard J.M.T., Forster C.C., Carter M.L., Sicinski P., Ross M.E. Cerebellar histogenesis is disturbed in mice lacking cyclin D2. Development. 126:1999;1927-1935.
26. Preclikova H., Bryja V., Pachernik J., Krejci P., Dvorak P., Hampl A. Early cycling-independent changes to p27, cyclin D2 and cyclin D3 in differentiating mouse embryonal carcinoma cells. Cell Growth Differ. 13:2002;421-430.
27. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13:2003;65-70.
28. Fantl V., Stamp G., Andrews A., Rosewell I., Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:1995;2364-2372.
29. Sicinski P., Donaher J.L., Parker S.B., Li T., Fazeli A., Gardner H., Haslam S.Z., Bronson R.T., Elledge S.J., Weinberg R.A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:1995;621-630.
30. Kip1. Cell. 85:1996;721-732.
31. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell. 85:1996;707-720.
32. Ciemerych M.A., Kenney A.M., Sicinska E., Kalaszczynska I., Bronson R.T., Rowitch D.H., Gardner H., Sicinski P. Development of mice expressing a single D-type cyclin. Genes Dev. 16:2002;3277-3289.
33. Kip1 is haplo-insufficient for tumour suppression. Nature. 396:1998;177-180.